Cargando…

Apolipoprotein M Gene (APOM) Polymorphism Modifies Metabolic and Disease Traits in Type 2 Diabetes

This study aimed at substantiating the associations of the apolipoproein M gene (APOM) with type 2 diabetes (T2D) as well as with metabolic traits in Hong Kong Chinese. In addition, APOM gene function was further characterized to elucidate its activity in cholesterol metabolism. Seventeen APOM SNPs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jun-Wei, Tsui, Stephen K. W., Ng, Maggie C. Y., Geng, Hua, Li, Sai-Kam, So, Wing-Yee, Ma, Ronald C., Wang, Ying, Tao, Qian, Chen, Zhen-Yu, Chan, Juliana C. N., Ho, Yuan-Yuan
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044746/ https://www.ncbi.nlm.nih.gov/pubmed/21390319 http://dx.doi.org/10.1371/journal.pone.0017324

Ejemplares similares

Rosiglitazone Enhances Apolipoprotein M (Apom) Expression in Rat's Liver
por: Luo, Guanghua, et al.
Publicado: (2014)

APOE Genotype-Function Relationship: Evidence of −491 A/T Promoter Polymorphism Modifying Transcription Control but Not Type 2 Diabetes Risk
por: Geng, Hua, et al.
Publicado: (2011)

Functional Study of -724I/D Polymorphism in Apolipoprotein M (apoM) Gene Promoter Region and its Association with Myocardial Infarction
por: Guo, Hua, et al.
Publicado: (2015)

The FoxOs are in the ApoM house
por: Linton, MacRae F., et al.
Publicado: (2022)

Binding Characteristics of Sphingosine-1-Phosphate to ApoM hints to Assisted Release Mechanism via the ApoM Calyx-Opening
por: Zhang, Hansi, et al.
Publicado: (2016)

Interaction Effect of Genetic Polymorphisms in Glucokinase (GCK) and Glucokinase Regulatory Protein (GCKR) on Metabolic Traits in Healthy Chinese Adults and Adolescents
por: Tam, Claudia H.T., et al.
Publicado: (2009)

Correlation analysis between ApoM gene-promoter polymorphisms and coronary heart disease
por: Zhang, Yao, et al.
Publicado: (2016)

A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation
por: Hajny, Stefan, et al.
Publicado: (2017)

Meta-Analysis on the Correlation Between APOM rs805296 Polymorphism and Risk of Coronary Artery Disease
por: Sun, HongYan, et al.
Publicado: (2016)

The apoM/S1P Complex—A Mediator in Kidney Biology and Disease?
por: Bisgaard, Line S., et al.
Publicado: (2021)

ApoM is an important potential protective factor in the pathogenesis of primary liver cancer
por: Bai, Yaping, et al.
Publicado: (2021)

ApoM binds endotoxin contributing to neutralization and clearance by High Density Lipoprotein
por: Mousa, Hanaa, et al.
Publicado: (2023)

Using a multi-staged strategy based on machine learning and mathematical modeling to predict genotype-phenotype risk patterns in diabetic kidney disease: a prospective case–control cohort analysis
por: Leung, Ross KK, et al.
Publicado: (2013)

Endothelial Spns2 and ApoM Regulation of Vascular Tone and Hypertension Via Sphingosine‐1‐Phosphate
por: Del Gaudio, Ilaria, et al.
Publicado: (2021)

Genome-wide linkage scan for factors of metabolic syndrome in a Chinese population
por: Tam, Claudia HT, et al.
Publicado: (2010)

Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases
por: Jiang, Jingting, et al.
Publicado: (2008)

Increased expression levels of inflammatory cytokines and adhesion molecules in lipopolysaccharide-induced acute inflammatory apoM(−/−) mice
por: Shi, Yuanping, et al.
Publicado: (2020)

Non-negligible factors in studying the ApoM-S1P axis using EA.hy926 cells
por: Shi, Yuanping, et al.
Publicado: (2020)

Aldose Reductase Genotypes and Cardiorenal Complications: An 8-year prospective analysis of 1,074 type 2 diabetic patients
por: So, Wing-Yee, et al.
Publicado: (2008)

ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cells
por: Zhang, Xiao, et al.
Publicado: (2022)

LncRNA TUG1 regulates ApoM to promote atherosclerosis progression through miR‐92a/FXR1 axis
por: Yang, Liu, et al.
Publicado: (2020)

Association of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children
por: Hanh, Nguyen Thi Hong, et al.
Publicado: (2016)

Common Polymorphisms in MTNR1B, G6PC2 and GCK Are Associated with Increased Fasting Plasma Glucose and Impaired Beta-Cell Function in Chinese Subjects
por: Tam, Claudia Ha Ting, et al.
Publicado: (2010)

Apolipoprotein E polymorphisms are associated with ischemic stroke susceptibility in a Northwest China Han population
por: Zhao, Li-li, et al.
Publicado: (2017)

Dihydrocapsaicin down-regulates apoM expression through inhibiting Foxa2 expression and enhancing LXRα expression in HepG2 cells
por: Zhao, Jia-Yi, et al.
Publicado: (2014)

HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium
por: Ruiz, Mario, et al.
Publicado: (2017)

Genome-wide analysis of DNA methylation associated with HIV infection based on a pair of monozygotic twins
por: Zhang, Yinfeng, et al.
Publicado: (2015)

Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer
por: Mrkonjic, M, et al.
Publicado: (2009)

Apolipoprotein E polymorphisms and primary glaucoma in Saudis
por: Al-Dabbagh, Najwa Mohammed, et al.
Publicado: (2009)

Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians
por: Tam, Claudia H. T., et al.
Publicado: (2021)

Association Study of Apolipoprotein E Gene Polymorphism With Incidence and Delayed Resolution of Hemifacial Spasm
por: Zhou, Jianxin, et al.
Publicado: (2021)

Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke
por: Yuan, Shuai, et al.
Publicado: (2020)

Use of Net Reclassification Improvement (NRI) Method Confirms The Utility of Combined Genetic Risk Score to Predict Type 2 Diabetes
por: Tam, Claudia H. T., et al.
Publicado: (2013)

The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee
por: Strandhagen, Elisabeth, et al.
Publicado: (2004)

Apolipoprotein E-polymorphism, frailty and mortality in older adults
por: Rockwood, Kenneth, et al.
Publicado: (2008)

Association between Alzheimer’s Disease and Apolipoprotein E Polymorphisms
por: Gozalpour, E, et al.
Publicado: (2010)

Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
por: Ceci, Flavio M., et al.
Publicado: (2021)

ASSOCIATION BETWEEN APOLIPOPROTEIN E POLYMORPHISMS AND EPILEPSY IN CHILDREN
por: Kukuruzović, Monika, et al.
Publicado: (2021)

Study of Apolipoprotein E Polymorphism in Normal Healthy Controls from Northern India
por: Chhabra, S., et al.
Publicado: (2000)

Dietary quality indices modify the effects of apolipoprotein B polymorphisms on biochemical and anthropometric factors in type 2 diabetes mellitus
por: Karimi, Elmira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kninpgihd01o01lpdrdr29a128